TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Biotec Betaglucans AS
Closing information (x1000 SEK)
| Closing information | 2024/01 | 2023/01 | 2022/01 |
| Turnover |
32,073
|
16,854
|
27,128 |
| Financial expenses |
1,764
|
2,238
|
157 |
| Earnings before taxes |
3,392
|
2,456
|
69,270 |
| Total assets |
32,992
|
23,535
|
27,533 |
| Current assets |
25,079
|
20,449
|
25,258 |
| Current liabilities |
19,108
|
9,410
|
9,508 |
| Equity capital |
13,884
|
14,126
|
18,025 |
| - share capital |
993
|
1,041
|
1,047 |
Financial ratios
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Solvency |
42.1%
|
60.0%
|
65.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
10.6%
|
14.6%
|
255.3% |
| Return on assets (ROA) |
15.6%
|
19.9%
|
252.2% |
| Current ratio |
131.2%
|
217.3%
|
265.6% |
| Return on equity (ROE) |
24.4%
|
17.4%
|
384.3% |
| Change turnover |
16,001
|
-10,109
|
-24,846 |
| Change turnover % |
100%
|
-37%
|
-48% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.